Delivery Order SPE2DB22D3016-SPE2DB26FABD6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count packaging) with a ceiling value of $1,312.22. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for ultimate completion by October 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a contract ceiling value of $1,801.61. This firm fixed-price delivery order, which is set to conclude on September 30, 2025, represents a non-set-aside competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,190.65. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,276.11 to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The ultimate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $2,071.52. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in open federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a ceiling value of $1,173.84. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for completion by June 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count units) on May 12, 2025, with a ceiling value of $1,533.59 and an ultimate completion date of May 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,673.10. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by June 5, 2025. The product will be performed and delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count) with a ceiling value of $2,283.38. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABD6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a contract ceiling value of $1,000.46. This non-competitive delivery order utilizes firm fixed pricing and requires completion by November 4, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. The award represents a routine pharmaceutical supply transaction under the company's existing federal contract framework. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The parent indefinite delivery contract serves as a global pharmaceutical support vehicle enabling the company to fulfill diverse medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/3/25 |